Flucovag: efficacy and safety in patients with vulvovaginal candidiasis: a prospective, multicenter, open-label, randomized, comparative clinical study

Author:

Kutueva Flora R.,Glushakov Ruslan I.,Tapilskaya Natalia I.,Nikolaeva Alla E.,Poromov Artem A.,Pustotina Olga A.ORCID

Abstract

Design. A prospective, multicenter, open-label, randomized, comparative clinical study. Objective. To compare the efficacy and safety of Flucovag (sertaconazole) vaginal suppositories, 300 mg (OTCPharm JSC, Russia; manufactured by Altpharm LLC, Russia) and the brand-name drug Zalain (sertaconazole), 300 mg (Egis Pharmaceuticals PLC, Hungary) in the treatment of vulvovaginal candidiasis. Materials and methods. The study included female patients (1855 years old) with uncomplicated vulvovaginal candidiasis treated in outpatient settings. In total, 220 patients were randomized into two groups: group 1 (n=110) received a single dose of Flucovag vaginal suppositories, and group 2 (n=110) received a single dose of Zalain vaginal suppositories. Seven days after the treatment, its clinical efficacy was evaluated. In case of incomplete clinical improvement after 7 days, patients received an additional dose of Flucovag (n=4) or Zalain (n=5) suppositories, respectively. Results. At the end of therapy in the study groups, the clinical cure rates (99.1% vs. 96.3%, p0.05), microscopic, and culture results were comparable. No serious adverse events were reported in both groups throughout the study. Conclusion. The study results demonstrate a favorable safety profile and high antifungal activity of sertaconazole.

Publisher

Consilium Medicum

Subject

Obstetrics and Gynecology

Reference13 articles.

1. Jaeger M, Plantinga TS, Joosten LA, et al. Genetic basis for recurrent vulvo-vaginal candidiasis. Curr Infect Dis Rep. 2013;15(2):136-42.

2. Sobel JD. Vulvovaginal candidosis. Lancet. 2007;369(9577):1961-71.

3. Федеральные клинические рекомендации. Дерматовенерология 2015: Болезни кожи. Инфекции, передаваемые половым путем. 5-е изд., перераб. и доп. М.: Деловой экспресс, 2016 [Federal'nye klinicheskie rekomendatsii. Dermatovenerologiia 2015: Bolezni kozhi. Infektsii, peredavaemye polovym putem. 5-e izd., pererab. i dop. Moscow: Delovoi ekspress, 2016 (in Russian)].

4. Prevalence of Recurrent Vulvovaginal Candidiasis in 5 European Countries and the United States

5. Health-related quality of life as measured with the Short-Form 36 (SF-36) questionnaire in patients with recurrent vulvovaginal candidiasis

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3